| Catalog No. |
Size |
Price |
Figures |
|---|
Z00150-1 mg
| 1 mg | $ 1000.00 |
References:
- Lazzarotto T, et al. An in vivo study on active cytomegalovirus infection in relation to active HIV replication in HIV-I infected drug addicts. J. Infect. May 1994; 28 (3): 287-291.
|
|---|
| Full Name | | HIV-1 p24 Core, Human Immunodeficiency Virus Antigen, Recombinant |
|
| Abbreviated Name-1 | rHIV-Ip24c |
|---|
| Abbreviated Name-2 | HIVI p24 Core; HIV-1 p24 Core; HIV1 p24 Core |
|---|
| Description | E. coli derived recombinant. GenScript Human Immunodeficiency Virus (HIV)-1 p24 Core contains the full length sequence of HIV-1 p24. |
|---|
| Purity | Protein is >95% pure (As determined by HPLC-C4, and 10% PAGE). |
|---|
| Storage | Reagent is shipped at ambient temperature. Freeze upon arrival. |
|---|
| Concentration | 1 mg/ml in 50 mM Tris, pH 7.2, 8 M urea |
|---|
| Stability | Five years frozen. Six months in solution at 4°C. |
|---|
| Specificity | Immunoreactive with all sera of HIV-1 infected individuals |
|---|
| Applications | Antigen in ELISA and Western blots, excellent antigen for early detection of HIV seroconvertors with minimal specificity problems |
|---|
